NVC-422: Antiinfective agent treatment of impetigo treatment of conjunctivitis treatment of urinary tract infections

Drugs of the Future

Volumn 36, Issue 9, 2011, Pages 651-656

  Darouiche, R ^a   Najafi, R ^b   Krantz, K ^b   Debabov, D ^b   Friedman, L ^b   Khosrovi, B ^b   Wang, L ^b   Iovino, S ^b   Anderson, M ^b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b NovaBay Pharmaceuticals Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 (DICHLOROAMINO) 2 METHYLPROPANE 1 SULFONIC ACID N,N DICHLORO 2,2 DIMETHYLTAURINE; AGANOCIDE; AL 46383A; NVC 422; TAURINE DERIVATIVE; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL INFECTION; BACTERICIDAL ACTIVITY; CLINICAL TRIAL (TOPIC); CONJUNCTIVITIS; DRUG INDICATION; DRUG SAFETY; DRUG STABILITY; DRUG SYNTHESIS; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; IMPETIGO; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; UNSPECIFIED SIDE EFFECT;

EID: 84952983723     PISSN: 03778282     EISSN: None     Source Type: Journal    
DOI: 10.1358/dof.2011.036.09.1622081     Document Type: Article

References (26)

1. Shiau, T.P., Houchin, A., Nair, S., Xu, P., Low, E., Najafi, R., Jain, R. Stieglitz rearrangement of N,N-dichloro-beta,beta-disubstituted taurines under mild aqueous conditions. Bioorg Med Chem Lett 2009, 19(4): 1110-4.
2. Braghiroli, D., DiBella, M. New methods for the preparation of 2-amino-2- methylpropanesulfonic acid. Tetrahedron Lett 1996, 37(40): 7319-.
3. Ilson, B.E. et al. Effect of a new synthetic hexapetide to selectively stimulate growth hormone release in healthy human subjects. J Clin Endocrinol Metab 1989, 69(1): 212.
4. Wang, L., Khosrovi, B., Najafi, R. N-Chloro-2,2-dimethyltaurines: A new class of remarkably stable N-chlorotaurines. Tetrahedron Lett 2008, 49(14): 2193-5.
5. Debabov, D. NVC-422, a novel n-chlorotaurine derivative as topical antimicrobial. Drug Discov Chem 2010, Abst.
6. Najafi, R., Wang, L., Bassiri, M., Yang, J. (NovaBay Pharmaceuticals, Inc.). N,N-Dihalogenated amino acids and derivatives. CA 2535926, EP 1656095, JP 2007502826, US 2005065115, US 7462361, WO 2005020896.
7. Levy, S.B. Active efflux mechanisms for antimicrobial resistance. Antimicrob Agents Chemother 1992, 36(4): 695-703.
8. Taubes, G. The bacteria fight back. Science 2008, 321(5887): 356-61.
9. Thorpe, D.S. Combinatorial chemistry: Starting the second decade. Pharmacogenomics J 2001, 1(4): 229-32. (Pubitemid 33756645)
10. Gordon, Y.J., Romanowski, E.G., McDermott, A.M. A review of antimicrobial peptides and their therapeutic potential as anti-infective drugs. Curr Eye Res 2005, 30(7): 505-15. (Pubitemid 41113552)
11. Sutcliffe, J.A. Improving on nature: Antibiotics that target the ribosome. Curr OpinMicrobiol 2005, 8(5): 534-42. (Pubitemid 41355033)
12. Poole, K. Efflux-mediated antimicrobial resistance. J Antimicrob Chemother 2005,56(1): 20-51. (Pubitemid 41418335)
13. Maillard, J.Y. Bacterial resistance to biocides in the healthcare environment: should it be of genuine concern? J Hosp Infect 2007, 65(Suppl. 2): 60-72.
14. Badwey, J.A., Karnovsky, M.L. Active oxygen species and the functions of phagocytic leukocytes. Annu Rev Biochem 1980, 49: 695-726.
15. Cunningham, C., Tipton, K.F., Dixon, H.B. Conversion of taurine into Nchlorotaurine (taurine chloramine) and sulphoacetaldehyde in response to oxidative stress. Biochem J1998, 330(Pt. 2): 939-45. (Pubitemid 28112000)
16. Nagl, M., Hess, M.W., Pfaller, K., Hengster, P., Gottardi, W. Bactericidal activity of micromolar N-chlorotaurine: evidence for its antimicrobial function in the human defense system. Antimicrob Agents Chemother 2000, 44(9): 2507-13. (Pubitemid 30650903)
17. Davies, J.M., Horwitz, D.A., Davies, K.J. Inhibition of collagenase activity by N chlorotaurine, a product of activated neutrophils. Arthritis Rheum 1994, 37(3): 424-7. (Pubitemid 24093635)
18. Francavilla, C., Low, E., Nair, S. et al. Quaternary ammonium N,N-dichloroamines as topical, antimicrobial agents. Bioorg Med Chem Lett 2009, 19(10): 2731-4.
19. Low, E., Nair, S., Shiau, T. et al. N,N-Dichloroaminosulfonic acids as novel topical antimicrobial agents. Bioorg Med Chem Lett 2009, 19(1): 196-8.
20. Iovino, S.M., Krantz, K.D., Blanco, D.M. et al. NVC-422 topical gel for the treatment of impetigo. Int J Clin Exp Pathol 2011, 4(6): 587-95.
21. Wang, L., Belisle, B., Bassiri, M. et al. Chemical characterization and biological properties of NVC-422, a novel, stable N-chlorotaurine analo.g Antimicrob Agents Chemother 2011, 55(6): 2688-92.
22. Debabov, D., Georgopapadakou, N., Alvarez, N., Zuch, M., Belisle, B. Low frequency of spontaneous resistance and low potential for cross-resistance to N,N-dichloro-2,2 dimethyltaurine (NVC-422). 48th Annu Intersci Conf Antimicrob Agents Chemother (ICAAC) Infect Dis Soc Am (IDSA) Annu Meet (Oct 25-28, Washington DC) 2008, Abst F1-3943.
23. Najafi, K.K., Wilmarth, S., Najafi, R. et al. In vitro microbiocidal activity in tears of N,N-dichloro-2,2-dimethyltaurine (NVC-422, AL-46383A), a novel topical ophthalmic agent. Annu Meet Assoc Res Vision Ophthalmol (ARVO) (May 2-6, Fort Lauderdale) 2010, Abst 1992-D1029.
24. th Intersci Conf Antimicrob Agents Chemother (ICAAC) (Sept 12-15, Boston) 2010, Abst K-2199.
25. Bjorkman, J., Nagaev, I., Berg, O. G., Hughes, D., Andersson, D. I. Effects of environment on compensatory mutations to ameliorate costs of antibiotic resistance. Science 2000, 287(5457): 1479-82. (Pubitemid 30127140)
26. Farrell, D.J., Robbins, M., Rhys-Williams, W., Love, W.G. Investigation of the potential for mutational resistance to XF-73, retapamulin, mupirocin, fusidic acid, daptomycin and vancomycin in methicillin-resistant Staphylococcus aureus isolates during a 55-passage study. Antimicrob Agents Chemother 2011, 55(3): 1177-81.